The European Union approved the single-shot Johnson & Johnson vaccine — the fourth jab to get the green light for the 27-nation bloc.
The decision offers a boost for the EU’s sluggish vaccination programme. J&J said it aims to begin delivery to the bloc in the second half of April and to supply 200 million doses to the EU, Norway and Iceland in 2021.
The European Commission formally gave the green light for the jab after the Amsterdam-based European Medicines Agency recommended approval.
EU Commission President Ursula von der Leyen said in a tweet, “More safe and effective vaccines are coming to the market. We have just authorised the use of Johnson & Johnson’s vaccine in the EU…. With the number of doses we ordered, we could vaccinate up to 200 million people in the EU” with the J&J jab this year.
As well as being the first that requires a single injection as opposed to two, the Johnson & Johnson vaccine is easier to store.